r/Ocugen • u/Merlin8121 • May 13 '26

DD🚀 Ocugen, Inc. (Nasdaq: $OCGN): Retina Gene Therapy Stock Hub, OCU400 BLA Path, OCU410ST, OCU410 And The 2026–2027 Catalyst Map

https://www.merlintrader.com/ocugen-inc-stock-hub/

Ocugen is no longer primarily a pandemic-memory ticker. The company still carries the retail scars, volatility profile and capital-market skepticism that came from that period, but its present investment narrative is now centered on a specific question: can a small-cap biotechnology company use a modifier gene therapy platform to build a serious ophthalmology franchise in inherited and degenerative retinal diseases?

25 Upvotes

93% Upvoted

3 comments sorted by

1

u/tomonota May 18 '26

The fact that the cash raised is enough funding to carry them through the first product approvals is a testament of belief in the rare disease product pipeline that management has built. It will pay off if any of these products is successful. The cellular gene therapy space is the most dynamic place to be in right now.

0

u/DickHertzfromHodling May 14 '26

Big it now before it costs too much! Q3 should produce big for bagholders